FDA product code QWI: Computerized Behavioral Therapy Device For The Treatment Of Fibromyalgia Symptoms

QWI is the FDA product code for computerized behavioral therapy device for the treatment of fibromyalgia symptoms. It is a Class II device, regulated under 21 CFR 882.5804 and reviewed by the Physical Medicine panel. Devices under QWI reach the market by 510(k); FDA lists no cleared 510(k)s for it. 1 De Novo request was granted under it.

Definition

Provides acceptance and commitment therapy (ACT), a form of cognitive behavioral therapy (CBT), for patients with fibromyalgia symptoms

Classification

FieldValue
Device nameComputerized Behavioral Therapy Device For The Treatment Of Fibromyalgia Symptoms
Device classClass II
Regulation21 CFR 882.5804
Review panelPM — Physical Medicine
Medical specialtyNeurology
Premarket route510(k)

Recalls for QWI devices

FDA recall records list no recalls for product code QWI.

Frequently asked questions

What is FDA product code QWI?

QWI is the FDA product code for computerized behavioral therapy device for the treatment of fibromyalgia symptoms. It is a Class II device, regulated under 21 CFR 882.5804 and reviewed by the Physical Medicine panel.

What device class is QWI?

Class II, regulation 21 CFR 882.5804. Typical premarket route: 510(k).

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Physical Medicine product codes · FDA product code lookup · 510(k) database search · 510(k) review times